NCT06394349View on ClinicalTrials.gov

Platelet-rich Plasma Intradermal Injection Combined With 308 nm Excimer Light for Treating Stable Acral Vitiligo

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

October 14, 2024

Conditions

Vitiligo

Interventions

COMBINATION_PRODUCT

PRP+308nm

PRP+308nm

COMBINATION_PRODUCT

NS+308nm

NS+308nm

Trial Locations (1)

200040

RECRUITING

Huashan Hospital, Shanghai

All Listed Sponsors

lead

Yijian Zhu

OTHER